21 May 2013
Keywords: baxter, donation, glaxo, received, marketing, approval, reimbursement
Article | 08 August 1994
- Glaxo has received marketing approval and reimbursement status for
Serevent (salmeterol xinafoate) in France.
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 April 1994
14 February 1994
20 May 2013
© 2013 thepharmaletter.com